[Gallium-67 scintigraphy in malignant lymphoma].
The presence of a residual mass is a frequent and difficult problem in the treatment of Hodgkin's or non-Hodgkin's lymphoma: since it is of major importance to determine whether the lesion is a fibrous mass or a still progressing tumour requiring additional therapy. Gallium-67 scanning, performed in a series of 52 patients, provides an answer to this question since there is an excellent correlation between gallium uptake by the tumoral masses and their progressiveness. Magnetic resonance imaging was carried out in half of our patients: the finding of a low-intensity signal on T2-weighted sequences proved that the residual mass was fibrous, whereas a high-intensity signal on T2-weighted sequences did not distinguish between fibrous and tumour masses. The priceless information provided by the simple and non invasive method that is gallium scanning is extremely useful to evaluate the extension of lymphomas and to determine whether residual masses are tumoral or fibrous.
Cohen-Haguenauer
O
O
Service de Médecine nucléaire, Hôpital Saint-Louis, Paris.
Brice
P
P
Gaci
M
M
Le Pailleur
A
A
Cheval
E
E
Bris
C
C
Frija
J
J
Gisselbrecht
C
C
Rain
J D
JD
Najean
Y
Y
D000328:Adult; D005069:Evaluation Studies as Topic; D005500:Follow-Up Studies; D005710:Gallium Radioisotopes; D006689:Hodgkin Disease / Q000000981:diagnostic imaging / Q000473:pathology; D006801:Humans; D008223:Lymphoma / Q000000981:diagnostic imaging* / Q000473:pathology; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009367:Neoplasm Staging; D011877:Radionuclide Imaging
D005710:Gallium Radioisotopes
Apport de la scintigraphie au gallium-67 dans les lymphomas malins.